Second Clinical Trial Getting Underway for PathMaker's Non-Invasive ALS Treatment Platform. BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker”), ...
In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback